PG
48
7
WHR
70
2
ILMN
46
-4
XRX
37
2
PYPL
52
2
EIX
69
7
MAS
62
4
LLY
50
11
NOC
54
4
HSIC
45
11
LMT
39
4
ADM
17
-3
HBI
59
-6
WDC
50
-2
LEN
55
6
NTAP
64
3
PBI
59
-4
DE
35
-13
SE
50
-5
LOW
56
3
PG
48
7
WHR
70
2
ILMN
46
-4
XRX
37
2
PYPL
52
2
EIX
69
7
MAS
62
4
LLY
50
11
NOC
54
4
HSIC
45
11
LMT
39
4
ADM
17
-3
HBI
59
-6
WDC
50
-2
LEN
55
6
NTAP
64
3
PBI
59
-4
DE
35
-13
SE
50
-5
LOW
56
3
Financhill
Back

Checkpoint Therapeutics 10K Form

Sell
39

CKPT
Checkpoint Therapeutics

Last Price:
3.38
Seasonality Move:
2.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CKPT News And Ratings

See the #1 stock for the next 7 days that we like better than CKPT

CKPT Financial Statistics

Sales & Book Value

Annual Sales: $103K
Cash Flow: $-6.24M
Price / Cash Flow: 0
Annual Sales: $-0.37
Price / Book: 0

Profitability

EPS (TTM): -1.90000
Net Income (TTM): $-42.47M
Gross Margin: --
Return on Equity: 0%
Return on Assets: -632.35%

Checkpoint Therapeutics Earnings Forecast

Key Checkpoint Therapeutics Financial Ratios

  • The Research & Development expenses have been 42,297.09% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of CKPT is -50,336.89% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 5 years.

Checkpoint Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CKPT
CUSIP: 162828
Website: checkpointtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.26
Quick Ratio: 0.23

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CKPT Technical Analysis vs Fundamental Analysis

Sell
39
Checkpoint Therapeutics (CKPT) is a Sell

Is Checkpoint Therapeutics a Buy or a Sell?